Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v4-EN
Language French English
Date Updated 2019-05-27 2019-05-27
Drug Identification Number 02259893 02259893
Brand name TIZANIDINE TIZANIDINE
Common or Proper name Tizanidine Tizanidine
Company Name APOTEX INC APOTEX INC
Ingredients TIZANIDINE TIZANIDINE
Strength(s) 4MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100MG 100MG
ATC code M03BX M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-04-29 2019-04-29
Estimated end date 2019-05-10 2019-05-10
Actual end date 2019-05-15 2019-05-15
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments